Weight Gain After Stopping Wegovy: What Actually Happens

What the trial data tell us about weight gain after Wegovy

The clearest picture comes from the STEP 1 withdrawal study, a one-year extension of the original STEP 1 trial published in Nature Medicine. Participants who had lost around 17% of their body weight on semaglutide 2.4mg were randomised to either continue the medicine or switch to placebo. By week 120, those who stopped had regained roughly 11.6 percentage points of that loss — recovering most of what they had lost. Those who stayed on treatment continued to maintain their lower weight.

That pattern is consistent across the broader semaglutide evidence base. The NHS medicines page for semaglutide notes that weight management medicines are intended to be used as part of a long-term plan, not a short course. This matters because obesity is a chronic condition shaped by hormones, genetics, and metabolic set points, not simply a diet problem that resolves once weight falls.

The mechanism is straightforward. Semaglutide acts on GLP-1 receptors in the brain and gut, reducing appetite and slowing gastric emptying. Remove that signal and appetite returns, often to pre-treatment levels. The body's drive to restore its previous weight is powerful, and for many people it reasserts itself within weeks of the final dose. This is the biological reality that underpins why do you gain weight after Wegovy is one of the most searched questions about the medicine.

Factors that influence how much weight comes back

Not everyone regains at the same rate, and the degree of regain after semaglutide depends on several things working together. How long you were on treatment matters: people who spent more time building sustainable eating patterns during treatment tend to fare better. The dose you were at when you stopped also plays a role, as does whether the stopping was planned and gradual or abrupt.

Lifestyle habits carry significant weight here, literally. Participants in the STEP trials who combined semaglutide with structured dietary and activity support generally maintained more of their loss after stopping than those who relied on the medicine alone. The NHS's weight-management guidance consistently frames physical activity and dietary change as the durable component; medicine accelerates and supports those changes, but it cannot substitute for them. If you stopped Wegovy without a structured plan in place, that gap is often where regain accelerates.

Mental health, sleep, and stress also influence weight after stopping. A return of appetite is one thing; a return of appetite alongside disrupted sleep and higher cortisol is considerably harder to manage. People who used the lower-appetite window of treatment to address those areas often report a gentler rebound.

For a practical overview of how to minimise weight regain after Wegovy, including dietary strategies and activity goals, that page covers the evidence in detail.

The conversation about continuing, pausing, or switching

Stopping Wegovy does not have to mean an irreversible end to treatment. Some people move to a lower maintenance dose rather than coming off entirely. Others transition to tirzepatide (Mounjaro), which acts on two gut-hormone receptors rather than one and has shown greater average weight loss in head-to-head trials. Some take a planned break and return to semaglutide when circumstances allow. None of these choices should be made unilaterally.

The relevant question for your prescriber is not just whether to stop, but what the plan is for the day after your last pen. If that conversation hasn't happened yet, it's worth having before you reach the end of your supply. You can also read about what weight loss after Wegovy typically looks like over time to understand what a realistic maintenance trajectory means for you.

A note on cost: if the reason for stopping is financial, it is worth reviewing what a treatment package actually includes before deciding. Our cost context page explains what drives price variation between providers and what is typically bundled into a monthly fee. Stopping treatment to save money makes sense only if the comparison is genuinely like-for-like.

What to do if you are already experiencing weight gain after stopping

If you have already stopped Wegovy and are watching the weight return, the first thing worth knowing is that this is not inevitable in full. Partial regain is common; complete regain to your starting point is not universal, and acting early changes the trajectory.

Prioritising protein at each meal blunts hunger somewhat and protects muscle mass, which tends to be lost alongside fat during the weight regain phase. Resistance exercise has a similar protective effect. These are not revolutionary ideas, they are what NHS Better Health's guidance on maintaining weight loss recommends for exactly this situation.

If regain is significant and distressing, speaking to a prescriber about restarting or switching treatment is a reasonable step. Gaining weight after Wegovy is a clinical pattern that prescribers see regularly; it is not a sign that treatment failed or that you are not a suitable candidate going forward. You can find more detail on the semaglutide treatment overview and on whether weight regain is reversible. The clinical team at nume reviews each case individually, so the starting point is a consultation rather than a general rule.

If you would like to talk through your options, speak to our prescribers, consultations are free, reviewed the same day, and carry no obligation.